NMN vs NAD vs NR: which one should you take?
Last updated: July 2026 · By Eleanor Voss · 9-minute read
The short answer: NAD+ is the molecule your cells use. NMN and NR are two different raw materials your body converts into it. You do not take NAD+ orally, because the molecule is too large to survive digestion, which is why the shelf is full of precursors instead. Between the two precursors, NR has more published human trials and a longer regulatory history; NMN has the newer research and often the lower price per gram. Neither has been shown to beat the other on a health outcome.
Three letters combinations, sold in the same aisle, described in almost identical marketing language. It is not surprising that people buy one thinking they bought another. This page separates them, then says plainly what the evidence does and does not support about each.
Just want the recommendation?
Read enough already? To see which products actually contain a studied dose, the comparison covers five of them on evidence, dosage and guarantee length.
What each one actually is
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell, running more than 500 enzymatic reactions. It is the thing you are trying to raise. It is not, in practice, the thing you buy: the molecule is large and charged, and it does not survive the digestive tract intact in useful quantities. Products labelled as oral NAD+ are betting on delivery technology rather than on the molecule crossing unaided.
NMN (nicotinamide mononucleotide) is one step away from NAD+ in the salvage pathway. Your body converts it, and multiple human trials have confirmed that oral NMN raises circulating NAD+.
NR (nicotinamide riboside) is two steps away. It converts to NMN first, then to NAD+. It is the precursor with the longest commercial history, sold most visibly as Niagen and in products like Tru Niagen.
NADH supplement products show up on the same shelf and belong in a different category. It is NAD+ carrying an extra electron, the reduced form, not a precursor. It has its own small research literature, mostly around fatigue, and a thinner evidence base than either precursor.
Who this comparison is for, and who it's not
Who it's for: someone who has decided to try a NAD+ precursor and wants to know which molecule to spend on, or someone still deciding whether any of them is worth it. Both questions get answered here.
Who it's not for: anyone looking for a recommendation on NAD IV drips or injections. Those are a clinical service with a different evidence base and a different price bracket, and this page does not cover them. Also not for anyone on medication or managing a health condition, where the question stops being which molecule and becomes a conversation with a doctor.
How we assess this. We do not test products. Every claim here is read off published human trials and manufacturer disclosures, and where a study is named we link it so you can check the numbers yourself. Where the evidence is thin, we say it is thin rather than filling the gap with mechanism.
NMN vs NR side by side (and NAD+ vs NMN, which is a different question)
| NAD+ | NMN | NR | |
|---|---|---|---|
| What it is | The coenzyme itself | Direct precursor | Precursor, one step further back |
| Steps to NAD+ | None | One | Two |
| Survives digestion? | Poorly | Yes | Yes |
| Human trials | Few oral; most data is IV | Growing; several dose-finding trials | The largest published set |
| Studied daily dose | Not established orally | 300–900 mg | 100–1,000 mg |
| Regulatory status (US) | Sold as supplement | Contested; FDA position has shifted | Established NDI status |
| Typical cost per month | Varies widely | Often lower per gram | Often higher per gram |
NR vs NMN: what the human evidence supports for each
For NMN, the settled finding is that it raises NAD+ in humans. A 2022 dose-finding study in GeroScience tested 300, 600 and 900 mg daily and found significant elevation at all three, with the largest increases at the top dose. Beyond raising the marker, the outcome data is modest: small improvements in walking distance and some measures of muscle function in older adults, nothing that supports language about reversing aging.
For NR, the picture is similar in shape and larger in volume. It reliably raises NAD+, has been through more human trials than NMN, and has the same gap between the biomarker result and the health outcome. A 2018 trial in Nature Communications established the NAD+ elevation clearly; the downstream benefits have been harder to pin down.
The honest summary for both: the marker moves, and what the marker buys you is still an open question. Anyone telling you otherwise about either molecule is ahead of the data.
One phrasing worth untangling before moving on. People search NAD vs NMN and NAD+ vs NMN as if the two were competing products on a shelf. They are not: one is the destination and the other is a way of getting there. The real comparison, the one where you actually have to choose, is NMN against NR.
Which should you actually buy?
Three reasonable positions, depending on what you weight.
- Most human data behind it. Choose NR. More trials, longer track record, settled regulatory status in the United States.
- Whatever the current research is using. Choose NMN. The newer dose-finding work runs on NMN, and per gram it is often cheaper.
- Curious rather than committed, and price-sensitive. Consider whether either is worth it yet. Niacin raises NAD+ for a fraction of the cost, with flushing as the trade-off, and the case for the expensive precursors rests on avoiding that flush and on mechanisms that have not been shown to matter for outcomes.
What does not hold up is the idea that one of them is the breakthrough and the other is obsolete. That framing sells product; it does not describe the literature.
Liposomal NAD and resveratrol: two upsells worth checking before you pay
Liposomal NAD and liposomal NMN. The reasoning is sound: encase the molecule so more of it survives digestion. What is missing is a published head-to-head human trial showing liposomal NMN raises NAD+ more than standard NMN at the same dose. It may work. You are paying for a plausible mechanism, not a demonstrated result, and it is fair to want that stated plainly.
Resveratrol alongside it. The David Sinclair NMN protocol is where this pairing comes from, tracing to his lab work, where resveratrol activates enzymes that consume NAD+. Coherent theory. The human trial showing the combination beats NMN alone has not been published. Adding it is a reasonable bet, not a requirement, and it should not be the reason a product costs twice as much.
NAD+ dosage and what else to check on the label
Four things separate a product worth the money from one that is priced like it is.
- NAD+ dosage per serving, against the studied range. If the trials used 300 to 900 mg and the label says 250 mg, one serving a day sits below what was tested.
- Whether the dose is per capsule or per serving. A 500 mg serving of two capsules is 250 mg per capsule, and the bottle count halves.
- Third-party testing. Purity matters more here than in most categories, because independent testing has repeatedly found NMN products containing less than the label claims.
- Guarantee length against trial length. The trials ran 8 to 12 weeks before measuring. A 30-day guarantee expires before you could reasonably judge the product.
Where this leaves you
NAD+ decline with age is real and well documented. That both NMN and NR raise NAD+ in humans is also real and well documented. The leap from those two facts to a promise about how you will feel in six months is where the marketing lives, and it is a leap nobody has published the evidence for.
The reasonable version of trying one: pick a product whose dose matches the studied range, buy from a company that publishes third-party testing, give it the eight to twelve weeks the trials used, and decide for yourself. To see which products clear those bars, the comparison covers five of them. For the evidence in more depth first, what 14 human trials found goes through the studies one by one, and what NAD+ actually is covers the mechanism.
Common questions
Is NMN the same as NAD?
No, and the confusion is worth clearing up because it changes what you buy. NAD+ is the molecule your cells actually use. NMN is a precursor: a raw material your body converts into NAD+. Buying NAD+ itself as an oral supplement makes little sense, because the molecule is too large to survive digestion intact. That is why the shelf is full of precursors rather than NAD+ itself.
Which is better, NMN or NR?
Both raise NAD+ in humans and neither has been shown to beat the other on a health outcome. NR has the longer regulatory history and more published human trials. NMN has the louder research momentum and, in some markets, the lower price per gram. If you want the option with the most human data behind it, that is NR. If you want the one the newer trials are using, that is NMN.
What about NADH? Is that a fourth thing?
NADH is the reduced form of NAD+, the same molecule carrying an extra electron. It is sold as a supplement and has its own small body of research, mostly around fatigue. It is not a precursor in the way NMN and NR are, and the evidence base is thinner than for either of them.
How much NMN should I take?
The human trials that found significant NAD+ elevation used 300 to 900 mg daily, with higher doses producing larger increases. Most retail products sit at 250 to 500 mg per serving, which means a single daily serving of many products lands at the bottom of the studied range or below it. Check the label against that range before you judge the price.
Is liposomal NMN worth paying more for?
In theory liposomal delivery protects the molecule through digestion and improves absorption. In practice there is no published head-to-head human trial showing liposomal NMN raises NAD+ more than standard NMN at the same dose. It may help. Nobody has proven it does, and you are paying for the possibility.
Do I need resveratrol with it?
This pairing comes from the research of David Sinclair, whose lab work suggested resveratrol activates the enzymes that use NAD+. The reasoning is coherent and the human evidence for the combination outperforming NMN alone does not exist yet. It is a plausible addition, not an established requirement.
Can I just take niacin instead? It is much cheaper.
Niacin (vitamin B3) does raise NAD+ and costs a fraction of the price. The catch is flushing, which at the doses relevant here is uncomfortable enough that most people stop. Nicotinamide, the non-flushing form, also raises NAD+ but appears to inhibit some of the enzymes the whole approach is meant to support. The expensive precursors exist to route around both problems, and whether that is worth the markup is a fair question to ask yourself.